News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
GlaxoSmithKline
NEWS
JOBS
IN THE PRESS
NEWS
Business
GlaxoSmithKline’s CEO Emma Walmsley Tries to Conquer Old R&D Demons
August 7, 2017
·
1 min read
Business
GlaxoSmithKline to Shift Neuro R&D Out of China to Philadelphia Research Hub
August 4, 2017
·
3 min read
Drug Development
FDA Panel Votes to Recommend Dynavax’s Hepatitis B Vaccine; Hepsilav Can Compete With GlaxoSmithKline’s Engerix-B
July 31, 2017
·
2 min read
Business
CMOs Cringe as GlaxoSmithKline Will be Cutting Its Use by 25%
July 28, 2017
·
3 min read
Some GlaxoSmithKline Critics Would Prefer Walmsley Broke Up the Company
July 28, 2017
·
3 min read
GlaxoSmithKline CEO Kills 30+ Pre-Clinical and Clinical Programs
July 26, 2017
·
3 min read
Brace Yourself: GlaxoSmithKline’s New CEO Gets Ready to Overhaul the Drug Pipeline
July 24, 2017
·
3 min read
Business
Hundreds of Jobs to Go as GlaxoSmithKline Shutters Manufacturing Site
July 20, 2017
·
3 min read
Deals
New GlaxoSmithKline CEO Wants to Dump Another Business as it Prioritizes Pharma
July 19, 2017
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
GlaxoSmithKline and Genmab A/S Announce European Submission to Regulatory Authorities for Arzerra® (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)
October 4, 2013
·
1 min read
Deals
GlaxoSmithKline Unloads Thrombosis Brands, Manufacturing Facility to Aspen Pharmacare Ltd. for $1.13 Billion
October 1, 2013
·
1 min read
Job Trends
GlaxoSmithKline Opens New $40.6 Million Facility, 20 New Jobs Created
September 27, 2013
·
1 min read
BioCapital
FDA Strengthens Warnings for GlaxoSmithKline’s Arzerra and Genentech’s Rituxan
September 26, 2013
·
1 min read
GlaxoSmithKline and Baxter Healthcare Corporation Feature in Line Up at Smithers Rapra Extractables and Leachables European Conference 2013
September 25, 2013
·
1 min read
Business
GlaxoSmithKline’s China Revenues May be Down by 30% in Q3
September 25, 2013
·
1 min read
GlaxoSmithKline and Baxter Feature in Line up at Smithers Rapra Extractables and Leachables European Conference 2013
September 25, 2013
·
1 min read
Biotech Beach
Ligand Pharmaceuticals Inc. Partner GlaxoSmithKline Receives Marketing Authorization From the European Commission (EC) for Additional Revolade (Eltrombopag) Indication as the First Approved Treatment for Chronic Hepatitis C-Associated Thrombocytopenia
September 24, 2013
·
4 min read
Business
GlaxoSmithKline Inks $196 Million Biomedical Advanced Research and Development Authority (BARDA) U.S. Anthrax Treatment Deal
September 20, 2013
·
1 min read
Drug Development
GlaxoSmithKline, ProSensa Holding N.V.'s Muscular Dystrophy Drug Fails in Phase 3 Trial; ProSensa Stock Plunges -70.25% at Market Close on September 20, 2013
September 20, 2013
·
8 min read
